ClinicalTrials.gg

Program

HRS-9190

A development code. Also written as “HRS-9190; under Inhalational Anesthesia”, “HRS-9190; under Intravenous Anesthesia” and “[14C] HRS-9190”.

In Jiangsu HengRui Medicine's pipeline, nAChR. Its studies are led by Jiangsu HengRui Medicine.

Furthest: phase 3, since Jul 31, 20267 company-led studies, 2 open or runningNext primary completion: Dec 31, 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Jiangsu HengRui Medicine72 open or runningphase 3since Jul 31, 2026Apr 10, 2025Dec 31, 2026phase 3 · NCT07746726
  • Named in Jiangsu HengRui Medicine’s own pipeline as HRS-9190, phase 3, as of Jul 31, 2026 (source).

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 10, 2025First study: phase 1 study in Skeletal Muscle RelaxationFirst studyNCT06932315 · 53 enrolled · China
  2. Aug 8, 2025Phase 1 study in Skeletal Muscle RelaxationNCT07142850 · 49 enrolled · China
  3. Nov 14, 2025Phase 2 study in Neuromuscular BlockadeNCT07252921 · 70 enrolled · China
  4. Feb 5, 20262 phase 2 studies in Neuromuscular BlockadeNCT07404579, NCT07446309
  5. Mar 16, 2026Phase 1 study in Healthy Adult MaleNCT07494175 · 6 enrolled · China
  6. Jul 31, 2026Phase 3 study in Neuromuscular BlockadePhase 3 reachedNCT07746726 · 320 planned · China

Ahead

  1. Dec 31, 2026Primary completion: phase 3 study in Neuromuscular BlockadeNCT07746726

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 7 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07746726Neuromuscular Blockade · China3RecruitingDec 31, 2026320
NCT07494175Healthy Adult Male · China1Active, not recruitingMay 20266
NCT07446309Neuromuscular Blockade · China2CompletedJul 14, 202667
NCT07404579Neuromuscular Blockade · China2CompletedMay 15, 2026103
NCT07252921Neuromuscular Blockade · China2CompletedDec 30, 202570
NCT07142850Skeletal Muscle Relaxation · China1CompletedOct 31, 202549
NCT06932315Skeletal Muscle Relaxation · China1CompletedAug 13, 202553

How it is read

Names in the registry

  • “HRS-9190”, 9 entries
  • “HRS-9190; under Inhalational Anesthesia”, 1 entry
  • “HRS-9190; under Intravenous Anesthesia”, 1 entry
  • “[14C] HRS-9190”, 1 entry
  • “HRS-9190 for Injection”, 1 entry

Codes read as this program: HRS9190.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.